CHAD BAILEY: Open Payments
NPI 1093847717 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 25 payments from 10 companies in 2025. Trend: 2023 $494 · 2024 $335 · 2025 $739
Food & beverage: $686Education: $53
| Company | Payments | Amount |
|---|---|---|
| SPIRAIR, INC. | 1 | $151 |
| Regeneron Healthcare Solutions, Inc. | 6 | $138 |
| GENZYME CORPORATION | 4 | $117 |
| ALK-Abello, Inc | 4 | $75 |
| Optinose US, Inc. | 2 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $54 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Amgen Inc. | 1 | $23 |
Products named: DUPIXENT, SEPTALIGN, Xhance, NEFFY, NUCALA, TEZSPIRE, Ragwitek, TIMOTHY, STANDARDIZED.
Industry payments across TX — which companies pay providers there.
